Cerro Pacific Wealth Advisors’s GSK GSK Stock Holding History

Cerro Pacific Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8,322	Closed	-$281K	–	165
2025 Q1	$281K	Sell	8,322 -2,975	-26%	-$109K	0.09%	132
2024 Q4	$462K	Sell	11,297 -5,360	-32%	-$193K	0.15%	102
2024 Q3	$641K	Hold	16,657	–	–	0.24%	84
2024 Q2	$641K	Buy	+16,657	New	+$701K	0.25%	85
2023 Q1	$503K	Buy	14,127 +4,613	+48%	+$161K	0.28%	89
2022 Q4	$334K	Buy	+9,514	New	+$317K	0.18%	124
2022 Q3	–	Sell	-4,076	Closed	-$222K	–	144
2022 Q2	$222K	Buy	+4,076	New	+$225K	0.14%	134

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Cerro Pacific Wealth Advisors's GSK Position: Q2 2025 in Review

Cerro Pacific Wealth Advisors sold out of GSK (GSK) in Q2 2025, closing a stake of 8,322 shares — an estimated $281K sold.

Cerro Pacific Wealth Advisors first reported a position in GSK in Q2 2022 and held it in 7 quarters. The position peaked at $641K in Q3 2024. 892 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

Cerro Pacific Wealth Advisors reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
Cerro Pacific Wealth Advisors sold 8,322 GSK shares in Q2 2025, an estimated $281K.
Cerro Pacific Wealth Advisors first reported a position in GSK in Q2 2022 and held it in 7 quarters.
Cerro Pacific Wealth Advisors's GSK position peaked at $641K in Q3 2024.
892 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Cerro Pacific Wealth Advisors's 13F filing for Q2 2025, filed 25 Jul 2025.